Lumasiran Sodium, sold under the brand name Oxlumo, is a medication for the treatment of primary hyperoxaluria type 1 (PH1). Reference standards of Lumasiran Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Lumasiran Sodium
Catalogue No.:PA 12 1890000
CAS :
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
